ArticlePharmaceutics2022

Engineering of a Long-Acting Bone Morphogenetic Protein-7 by Fusion with Albumin for the Treatment of Renal Injury.

Mei Takano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.